Idexx Laboratories, Inc.’s recent filing unveils that its Director Claflin Bruce L. unloaded Company’s shares for reported $0.11 million on May 17 ’24. In the deal valued at $540.80 per share,200 shares were sold. As a result of this transaction, Claflin Bruce L. now holds 161 shares worth roughly $79253.86.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, POLEWACZYK JAMES F sold 8,104 shares, generating $4,525,596 in total proceeds. Upon selling the shares at $558.44, the Executive Vice President now owns 10,711 shares.
Before that, Vandebroek Sophie V. sold 1,404 shares. Idexx Laboratories, Inc. shares valued at $790,427 were divested by the Director at a price of $562.98 per share. As a result of the transaction, Vandebroek Sophie V. now holds 1,216 shares, worth roughly $0.6 million.
BTIG Research initiated its Idexx Laboratories, Inc. [IDXX] rating to a Buy in a research note published on July 25, 2024; the price target was $580. A number of analysts have revised their coverage, including Piper Sandler’s analysts, who decreased its forecast for the stock in late January from “an Overweight” to “a Neutral”. Exane BNP Paribas began covering IDXX with “an Outperform” recommendation on December 07, 2023. Cleveland Research revised its rating on December 04, 2023. It rated IDXX as “a Buy” which previously was an “a Neutral”.
Price Performance Review of IDXX
On Friday, Idexx Laboratories, Inc. [NASDAQ:IDXX] saw its stock jump 1.39% to $492.26. Over the last five days, the stock has gained 1.95%. Idexx Laboratories, Inc. shares have fallen nearly -11.31% since the year began. Nevertheless, the stocks have fallen -1.46% over the past one year. While a 52-week high of $583.39 was reached on 03/01/24, a 52-week low of $372.50 was recorded on 08/05/24. SMA at 50 days reached $485.05, while 200 days put it at $509.24.
Levels Of Support And Resistance For IDXX Stock
The 24-hour chart illustrates a support level at 482.78, which if violated will result in even more drops to 473.29. On the upside, there is a resistance level at 498.69. A further resistance level may holdings at 505.11. The Relative Strength Index (RSI) on the 14-day chart is 56.78, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 7.38, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 6.83%. Stochastics%K at 80.47% indicates the stock is a selling.
How much short interest is there in Idexx Laboratories, Inc.?
A steep rise in short interest was recorded in Idexx Laboratories, Inc. stocks on 2024-07-31, dropping by -0.25 million shares to a total of 2.44 million shares. Yahoo Finance data shows the prior-month short interest on 2024-06-28 was 2.69 million shares. There was a decline of -10.13%, which implies that there is a negative sentiment for the stock.
